Sonic Healthcare (STU:SAB) EBIT: €518 Mil (TTM As of Dec. 2025)


STU:SAB Sonic Healthcare Ltd STU:SAB
68 GF Score
Price €12.00
GF Value €20.02
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sonic Healthcare EBIT?

Sonic Healthcare STU:SAB -0.53% 68 EBIT is €518 Mil as of Dec. 2025. GuruFocus rates STU:SAB with a GF Score™ of 68/100 and a GF Value™ of €20.02 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Sonic Healthcare's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €273 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €518 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sonic Healthcare's annualized ROC % for the quarter that ended in Dec. 2025 was 4.70%. Sonic Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 26.62%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sonic Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.54%.

Sonic Healthcare  (STU:SAB) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sonic Healthcare's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=545.932 * ( 1 - 26.48% )/( (8104.224 + 8976.305)/ 2 )
=401.3692064/8540.2645
=4.70 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9061.684 - 741.712 - ( 380.313 - max(0, 1255.006 - 1470.754+380.313))
=8104.224

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9662.537 - 677.643 - ( 316.135 - max(0, 1435.701 - 1444.29+316.135))
=8976.305

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Sonic Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=545.932/( ( (1881.267 + max(1.4369999999996, 0)) + (2052.796 + max(166.056, 0)) )/ 2 )
=545.932/( ( 1882.704 + 2218.852 )/ 2 )
=545.932/2050.778
=26.62 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(754.406 + 128.117 + 113.747) - (741.712 + 31.578 + 221.543)
=1.4369999999996

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(882.942 + 156.207 + 89.006) - (677.643 + 45.655 + 238.801)
=166.056

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sonic Healthcare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=517.732/9340.860
=5.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonic Healthcare EBIT Related Terms

Sonic Healthcare EBIT Historical Data

* Premium members only.

The historical data trend for Sonic Healthcare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonic Healthcare EBIT Chart

Sonic Healthcare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,219.05 1,433.97 630.75 544.07 490.73

Sonic Healthcare Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 224.31 318.64 263.56 244.77 272.97

STU:SAB vs TMO, DHR, IDXX: EBIT Comparison

For the Diagnostics & Research subindustry, Sonic Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sonic Healthcare EV-to-EBIT vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sonic Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sonic Healthcare's EV-to-EBIT falls into.


STU:SAB
68GF Score
Sonic Healthcare Ltd STU:SAB
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonic Healthcare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €518 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €518 Mil mean?
Sonic Healthcare (STU:SAB) has a EBIT of €518 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sonic Healthcare.
Is Sonic Healthcare's EBIT too high?
Sonic Healthcare's current EBIT is €518 Mil. Overall, Sonic Healthcare has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonic Healthcare's EBIT compare to TMO and DHR?
Sonic Healthcare's EBIT of €518 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Diagnostics & Research company?
A good EBIT depends on the Medical Diagnostics & Research industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sonic Healthcare. Sonic Healthcare's current EBIT is €518 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonic Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sonic Healthcare (STU:SAB) is currently considered Significantly Undervalued. The stock's GF Value™ is €20.02, compared to a current price of €12.00 — trading 40.1% below its estimated fair value. The current EBIT is €518 Mil. Sonic Healthcare's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Sonic Healthcare (STU:SAB), the current EBIT is €518 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sonic Healthcare (STU:SAB) Overvalued in 2026?

Based on GuruFocus' analysis, Sonic Healthcare stock appears to be undervalued. The current stock price of €12.00 is trading 40.1% below its estimated GF Value™ of €20.02. GuruFocus considers Sonic Healthcare to be Significantly Undervalued.

Key valuation signals for STU:SAB:

  • EBIT: €518 Mil
  • GF Value™: €20.02 vs. price of €12.00 (40.1% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the STU:SAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sonic Healthcare Business Description

Address 225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
68GF Score

Get the complete analysis for STU:SAB

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.00
Price
€20.02
GF Value